Role of CD204-Positive Tumor-Associated Macrophages in Adult T-Cell Leukemia/Lymphoma
Authors:
Open Access
- 1 January 2014
- journal article
- Published by Japanese Society for Lymphoreticular Tissue Research in Journal of Clinical and Experimental Hematopathology
- Vol. 54 (1) , 59-65
Abstract
Adult T-cell leukemia/lymphoma (ATLL) is endemic in southwestern Japan, the Caribbean basin, and parts of central Africa, and is considered to be caused by long-term infection with human T-cell leukemia virus type I. CD204 is a scavenger receptor that is overexpressed on alternatively activated macrophages and is known to be overexpressed in tumor-associated macrophages (TAMs). CD206 is also considered a marker of alternatively activated macrophages. However, no studies have investigated CD206 and TAMs. In the present study, we investigated the significance of CD204+ and CD206+ TAMs in ATLL tissue samples. We also investigated the correlations with the Ki-67 labeling index (Ki-67LI) and the number of CD31+ vessels. We found that the number and ratio of CD204+ TAMs were closely associated with the Ki-67LI, which reflects lymphoma cell proliferation. The number of CD31+ vessels was not correlated with the number or ratio of CD204+ and CD206+ TAMs. The number and ratio of CD204+ and CD206+ TAMs, number of CD31+ vessels, and the Ki-67LI were not associated with the clinical outcome of patients with ATLL. Although further studies are necessary to uncover the detailed mechanisms of CD204 and lymphoma proliferation, these data may provide novel insight into the pathogenesis of ATLL. [J Clin Exp Hematop 54(1): 59-65, 2014]Keywords
This publication has 37 references indexed in Scilit:
- Interaction of monocytes/macrophages with ovarian cancer cells promotes angiogenesis in vitroCancer Science, 2013
- Coordinated regulation of myeloid cells by tumoursNature Reviews Immunology, 2012
- Mannose Receptor (MR) Engagement by Mesothelin GPI Anchor Polarizes Tumor-Associated Macrophages and Is Blocked by Anti-MR Human Recombinant AntibodyPLOS ONE, 2011
- Tumour macrophages as potential targets of bisphosphonatesJournal of Translational Medicine, 2011
- The classical Hodgkin's lymphoma microenvironment and its role in promoting tumour growth and immune escapeThe Journal of Pathology, 2010
- Ratio of M2 macrophage expression is closely associated with poor prognosis for Angioimmunoblastic T‐cell lymphoma (AITL)Pathology International, 2010
- Stat3 mediates myeloid cell–dependent tumor angiogenesis in miceJournal of Clinical Investigation, 2008
- Tumour-educated macrophages promote tumour progression and metastasisNature Reviews Cancer, 2004
- Alternative activation of macrophagesNature Reviews Immunology, 2003
- The role of tumour‐associated macrophages in tumour progression: implications for new anticancer therapiesThe Journal of Pathology, 2002